Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBelching is one of the more socially awkward side effects of Wegovy (semaglutide), and it catches a lot of people off guard. It happens because semaglutide slows how quickly food moves through your stomach — a mechanism that helps you feel full for longer but also gives gas more time to build. For most people, burping settles down within the first few weeks. It is worth knowing, though, that Wegovy is a prescription-only medicine and a clinician will assess whether it is appropriate for you before any treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide, the active medicine in Wegovy, activates GLP-1 receptors in the gut and brain. One of its effects is to slow gastric emptying, the rate at which your stomach pushes food into the small intestine. That slowing is deliberate: it prolongs the feeling of fullness and helps reduce how much you eat at each meal. The side effect is that air swallowed during eating, or gas produced as food is digested, lingers in the stomach longer than usual. The result is more frequent, sometimes forceful, burping.
The NHS's patient guidance on semaglutide lists burping (eructation) alongside nausea, vomiting, diarrhoea, constipation, and stomach discomfort as common side effects. That list is worth reading in full if you are early in treatment, because understanding which symptoms are expected helps you tell them apart from anything that needs attention. You can read the broader pattern of what people experience on Wegovy's side-effect profile across the treatment period.
Belching tends to be most noticeable in two situations: the first few weeks of treatment when your digestive system is adjusting, and the days following each dose increase. Once your stomach has adapted to a given dose level, many people find the burping fades considerably, though the 0.5 mg dose stage can bring its own adjustment symptoms that are useful to know about in advance.
There is no specific medication for Wegovy-related burping, but there are reliable ways to reduce it. The most effective changes address the root causes (swallowed air and delayed stomach emptying) directly.
Eat more slowly. A one-minute habit worth building: before you lift your fork for the next mouthful, put it down and finish chewing properly. Most people eat faster than they realise, swallowing extra air with each rushed bite. Smaller, more frequent meals give your stomach less to process at once, which tends to ease the burping. Fizzy drinks, including sparkling water, introduce gas directly into an already-slower system and are worth cutting out during the adjustment period.
Fatty and very rich foods also slow gastric emptying further (on top of what semaglutide is already doing) so meals that are lower in fat and higher in protein tend to sit more comfortably. Peppermint tea after meals is often mentioned anecdotally, though the evidence is limited; it does no harm. Avoiding lying down immediately after eating gives gravity a chance to help. If you want to explore whether your experience of side effects is typical, this overview of what people commonly report on Wegovy puts individual symptoms in context.
Most belching on Wegovy is a nuisance, not a warning sign. The symptoms that do need prompt medical attention are different in character: severe stomach pain that does not ease, pain that spreads into your back, or vomiting that is persistent and stops you keeping fluids down.
In January 2026 the MHRA issued a Drug Safety Update on GLP-1 medicines specifically flagging acute pancreatitis as a known, infrequent but serious risk. The key symptom is intense, constant abdominal pain that may radiate to the back, sometimes accompanied by vomiting. This is not the same as ordinary post-meal burping or bloating. If you develop that kind of pain, seek urgent medical help rather than waiting to see whether it passes. You can report any suspected side effects from Wegovy, including unexpected digestive symptoms, through the MHRA's Yellow Card scheme, this actively helps the MHRA track the safety of medicines in real-world use.
Severe vomiting or diarrhoea that goes on for more than a day or two also carries a dehydration risk, which can in turn affect kidney function. If you cannot keep fluids down, that is a reason to contact a healthcare professional, not to push through. Some people also notice skin reactions during treatment, and if you are wondering whether itching is a recognised semaglutide side effect, it is worth reading up so you know what to look out for. Our team at nume's support line is available seven days a week for aftercare questions, but for urgent symptoms your GP or 111 is the right first call.
If burping is severe enough to affect your daily life weeks into treatment, it is worth raising with your prescriber before assuming it will resolve. Persistent GI side effects can sometimes indicate that dose titration has moved too quickly for your system, and slowing the schedule is a legitimate clinical response. That decision sits with the prescriber; do not adjust your own dosing or timing without guidance.
Some people find that Wegovy's GI profile suits them less well than expected, and that is a reasonable thing to discuss openly. Not everyone experiences the same severity of side effects, individual variation is real and shaped by factors including diet, pace of titration, and overall health. For others, the side effects are mild enough that they barely register after the first month. If you are weighing whether the treatment is right for you at all, our treatment overview describes how the consultation process works and what it covers. Our prescribers discuss side effects as part of that assessment, including which symptoms to watch for and what to do if they arise. If you would like to check your eligibility, the consultation is free and reviewed the same day by a named, GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.